Blinded Rituximab



Indications and Reactions:

Role Indications Reactions
Primary
Drug Use For Unknown Indication 60.8%
Anti-neutrophil Cytoplasmic Antibody Positive Vasculitis 10.2%
Rheumatoid Arthritis 9.9%
Product Used For Unknown Indication 6.1%
Renal Transplant 3.9%
Dermatomyositis 2.1%
Hypertension 1.0%
Sjogren's Syndrome 1.0%
Glomerulonephritis 0.7%
Headache 0.7%
Vasculitis 0.7%
Prophylaxis 0.5%
Arthritis 0.3%
Chest Discomfort 0.3%
Coronary Artery Disease 0.3%
Depression 0.3%
Hypothyroidism 0.3%
Medical Diet 0.3%
Multiple Sclerosis 0.3%
Myopathy 0.3%
Cardiac Failure Congestive 8.5%
Leukopenia 8.5%
Osteomyelitis 8.5%
Squamous Cell Carcinoma 8.5%
Wegener's Granulomatosis 8.5%
Dehydration 6.4%
Hepatitis B Dna Increased 6.4%
Meningitis 6.4%
Hyperglycaemia 4.3%
Large Intestine Perforation 4.3%
Polyomavirus-associated Nephropathy 4.3%
Polyuria 4.3%
Serum Sickness 4.3%
Vertigo 4.3%
Acute Tonsillitis 2.1%
Anti-neutrophil Cytoplasmic Antibody Positive Vasculitis 2.1%
Benign Intracranial Hypertension 2.1%
Blood Creatinine Increased 2.1%
Breast Cancer 2.1%
Chest Pain 2.1%
Secondary
Diffuse Large B-cell Lymphoma 53.7%
Drug Use For Unknown Indication 31.9%
Product Used For Unknown Indication 6.1%
Non-hodgkin's Lymphoma 2.7%
B-cell Lymphoma 1.9%
Rheumatoid Arthritis 1.0%
Anti-neutrophil Cytoplasmic Antibody Positive Vasculitis 0.9%
Lymphoma 0.6%
Glomerulonephritis 0.1%
Headache 0.1%
Hodgkin's Disease 0.1%
Renal Transplant 0.1%
Depression 0.1%
Hypertension 0.1%
Prophylaxis 0.1%
Deep Vein Thrombosis 0.1%
Medical Diet 0.1%
Arthritis 0.1%
Chest Discomfort 0.1%
Hypothyroidism 0.1%
Febrile Neutropenia 42.3%
Neutropenia 10.5%
Pyrexia 4.4%
Pneumonia 3.6%
White Blood Cell Count Decreased 3.6%
Pulmonary Embolism 3.3%
Respiratory Failure 3.3%
Rectal Ulcer 3.0%
Ascites 2.8%
Mucosal Inflammation 2.8%
Squamous Cell Carcinoma 2.8%
Septic Shock 2.5%
Stomatitis 2.5%
Neutropenic Sepsis 2.2%
Splenic Abscess 2.2%
Blood Sodium Decreased 1.9%
Hyperglycaemia 1.7%
Oral Candidiasis 1.7%
Polyuria 1.7%
Death 1.4%